Biotech firm wins royalty fight
631783
UK biotech company Cambridge Antibody Technology (CAT) has won its court fight for bigger royalties from the sale of arthritis medicine Humira.
326432
Bio-Reference again showed it can compete with larger archrivals.
411558
The pharmaceutical sues over patent infringement.
25622
The German biotechnology company Paion and its American partner, Forest Laboratories, announced the outcomes of the trial of its drug, desmoteplase.
51447
Millionaires' club sets genome target A $10m carrot is being dangled at biotech firms to encourage them to redouble efforts to make genome sequencing available to individuals.â¦
253809
Cambridge Antibody Technology Group Plc has won a UK court case to get a bigger slice of sales of a potential blockbuster arthritis medicine, sending its shares more than 25 percent higher on Monday.
667096
The biotech's new cancer candidate passes phase 1 trials.
145826
American Oriental Bioengineering makes an acquisition.
321553
Blockbuster products help the biotech firm continue its stellar performance.
431939
Nokia and Qualcomm have entered a new round in their high-stakes fight over patent royalties.
709807
Biotechnology interests have scored big wins on Beacon Hill, but in Washington it's a different story.
513921
Genentech is borrowing a bit of the winemakerâs art to make biotech pharmaceuticals.
685744
The Medicines Company reacquires its own drug.
28653
Biotech and high technology, two key Massachusetts industries, are often seen as allies -- innovation-driven businesses that depend on a highly educated workforce. But this week they're on opposite sides of a fight playing out in Washington: How to overhaul the nation's patent system.
697697
A takeover attempt follows management shakeups at the biopharmaceutical firm.
657768
Pfizer Inc.  said on Tuesday  that it had won a patent case over its Lipitor drug in an Irish  court, which ruled a patent protecting the blockbuster  cholesterol fighter would be infringed by a competing product  from India&#39;s Ranbaxy Laboratories Ltd.
647520
The companies have lost a court ruling that may result in their paying royalties on an experimental cancer drug to an Israeli research institute.